CRISPR2 Trademark

Trademark Overview

On Monday, January 20, 2020, a trademark application was filed for CRISPR2 with the United States Patent and Trademark Office. The USPTO has given the CRISPR2 trademark a serial number of 88765574. The federal status of this trademark filing is REGISTERED as of Tuesday, May 16, 2023. This trademark is owned by KSQ Therapeutics, Inc.. The CRISPR2 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields
crispr2

General Information

Serial Number88765574
Word MarkCRISPR2
Filing DateMonday, January 20, 2020
Status700 - REGISTERED
Status DateTuesday, May 16, 2023
Registration Number7055692
Registration DateTuesday, May 16, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 11, 2020

Trademark Statements

Description of MarkThe mark consists of the letters "CRISPR" followed by the numeral "2" in superscript.
Pseudo MarkCRISPER TWO; CRISPER TO
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesDrug discovery services; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 24, 2020
Primary Code042
First Use Anywhere DateWednesday, April 5, 2023
First Use In Commerce DateWednesday, April 5, 2023

Trademark Owner History

Party NameKSQ Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameKSQ Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameKSQ Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, May 16, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 16, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, April 13, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, April 12, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 11, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 6, 2023USE AMENDMENT FILED
Thursday, April 6, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, December 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 9, 2022SOU EXTENSION 4 GRANTED
Thursday, October 6, 2022SOU EXTENSION 4 FILED
Friday, December 9, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 8, 2022NOTICE OF REVIVAL - E-MAILED
Tuesday, November 8, 2022EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 8, 2022PETITION TO REVIVE-GRANTED
Tuesday, November 8, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, November 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 12, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2022SOU EXTENSION 3 GRANTED
Monday, March 21, 2022SOU EXTENSION 3 FILED
Monday, March 21, 2022TEAS EXTENSION RECEIVED
Wednesday, October 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 4, 2021SOU EXTENSION 2 GRANTED
Monday, October 4, 2021SOU EXTENSION 2 FILED
Monday, October 4, 2021TEAS EXTENSION RECEIVED
Saturday, March 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 25, 2021SOU EXTENSION 1 GRANTED
Thursday, March 25, 2021SOU EXTENSION 1 FILED
Thursday, March 25, 2021TEAS EXTENSION RECEIVED
Tuesday, October 6, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 6, 2020ASSIGNED TO LIE
Wednesday, July 1, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 9, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 9, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 9, 2020NON-FINAL ACTION E-MAILED
Thursday, April 9, 2020NON-FINAL ACTION WRITTEN
Wednesday, April 8, 2020ASSIGNED TO EXAMINER
Friday, January 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 23, 2020NEW APPLICATION ENTERED

Related Keywords

crispr research fields services pharmaceuticals genetics information pharmaceutical biotechnology development providing